Light-Driven Cascade Mitochondria-to-Nucleus Photosensitization in Cancer Cell Ablation

52Citations
Citations of this article
17Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Nuclei and mitochondria are the only cellular organelles containing genes, which are specific targets for efficient cancer therapy. So far, several photosensitizers have been reported for mitochondria targeting, and another few have been reported for nuclei targeting. However, none have been reported for photosensitization in both mitochondria and nucleus, especially in cascade mode, which can significantly reduce the photosensitizers needed for maximal treatment effect. Herein, a light-driven, mitochondria-to-nucleus cascade dual organelle cancer cell ablation strategy is reported. A functionalized iridium complex, named BT-Ir, is designed as a photosensitizer, which targets mitochondria first for photosensitization and subsequently is translocated to a cell nucleus for continuous photodynamic cancer cell ablation. This strategy opens new opportunities for efficient photodynamic therapy.

Cite

CITATION STYLE

APA

Wang, K. N., Liu, L. Y., Qi, G., Chao, X. J., Ma, W., Yu, Z., … Liu, B. (2021). Light-Driven Cascade Mitochondria-to-Nucleus Photosensitization in Cancer Cell Ablation. Advanced Science, 8(8). https://doi.org/10.1002/advs.202004379

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free